The U.S. Food and Drug Administration on Tuesday approved the country's first over-the-counter continuous glucose monitor for type 2 diabetes. The new Dexcom Stelo Glucose Biosensor System, which will be available by summer, is intended for people 18 and older who have type 2 diabetes but d...
The US Food and Drug Administration (FDA) has approved the Dexcom G6 integrated continuous glucose monitoring (iCGM) system, the first such device designed to work with a range of other compatible medical devices. The Dexcom G6 is approved for use in adults and children (2 years of age or...
More than 25 million Americans have type 2 diabetes and do not use insulin, Dexcom noted. While the company's G7 CGM system is available to these folks, patients have to get a prescription for it. That changes with the arrival of an over-the-counter version of the tracking system. "Use...